Unknown

Dataset Information

0

Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.


ABSTRACT: To determine dose-dependent effects of T administration on cardiovascular risk markers in women with low T levels.Seventy-one hysterectomized women with or without oophorectomy with total T < 31 ng/dL and/or free T < 3.5 pg/mL received a standardized transdermal estradiol regimen during the 12-week run-in period and were then randomized to receive weekly im injections of placebo or 3-, 6.25-, 12.5-, or 25-mg T enanthate for 24 weeks. Total and free T levels were measured by liquid chromatography-tandem mass spectrometry and equilibrium dialysis, respectively. Insulin resistance and inflammatory markers were measured at baseline and 24 weeks. In a subset of women, magnetic resonance imaging of the abdomen was performed to quantify abdominal fat volume.Fifty-nine women who completed the 24-week intervention were included in the final analysis. The five groups were similar at baseline. Mean on-treatment nadir total T concentrations were 14, 79, 105, 130, and 232 ng/dL in the placebo group and the 3-, 6.25-, 12.5-, and 25-mg groups, respectively. No significant changes in fasting glucose, fasting insulin, homeostatic model assessment of insulin resistance, high sensitivity C-reactive protein, adiponectin, blood pressure, and heart rate were observed at any T dose when compared to placebo. Similarly, no dose- or concentration-dependent changes were observed in abdominal fat on magnetic resonance imaging.Short-term T administration over a wide range of doses for 24 weeks in women with low T levels was not associated with worsening of cardiovascular risk markers.

SUBMITTER: Huang G 

PROVIDER: S-EPMC4079305 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.

Huang Grace G   Tang Elizabeth E   Aakil Adam A   Anderson Stephan S   Jara Hernan H   Davda Maithili M   Stroh Helene H   Travison Thomas G TG   Bhasin Shalender S   Basaria Shehzad S  

The Journal of clinical endocrinology and metabolism 20140408 7


<h4>Objective</h4>To determine dose-dependent effects of T administration on cardiovascular risk markers in women with low T levels.<h4>Methods</h4>Seventy-one hysterectomized women with or without oophorectomy with total T < 31 ng/dL and/or free T < 3.5 pg/mL received a standardized transdermal estradiol regimen during the 12-week run-in period and were then randomized to receive weekly im injections of placebo or 3-, 6.25-, 12.5-, or 25-mg T enanthate for 24 weeks. Total and free T levels were  ...[more]

Similar Datasets

| S-EPMC6736210 | biostudies-literature
| S-EPMC7748292 | biostudies-literature
| S-EPMC3994001 | biostudies-literature
| S-EPMC3269509 | biostudies-literature
| S-EPMC3648456 | biostudies-literature
| S-EPMC3515039 | biostudies-other
| S-EPMC8137474 | biostudies-literature
| S-EPMC5384512 | biostudies-literature
| S-EPMC4716804 | biostudies-literature
| S-EPMC7644633 | biostudies-literature